Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3739989014 | Erythromycin and zinc acetate only product in cutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3739990017 | Product containing only erythromycin and zinc acetate in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Erythromycin and zinc acetate only product in cutaneous dose form | Is a | Erythromycin- and zinc acetate-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Erythromycin and zinc acetate only product in cutaneous dose form | Has active ingredient | Erythromycin | true | Inferred relationship | Some | 1 | |
Erythromycin and zinc acetate only product in cutaneous dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Erythromycin and zinc acetate only product in cutaneous dose form | Has active ingredient | Zinc acetate | true | Inferred relationship | Some | 2 | |
Erythromycin and zinc acetate only product in cutaneous dose form | Is a | Erythromycin and zinc acetate only product | true | Inferred relationship | Some | ||
Erythromycin and zinc acetate only product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
Erythromycin and zinc acetate only product in cutaneous dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution | Is a | True | Erythromycin and zinc acetate only product in cutaneous dose form | Inferred relationship | Some |
Reference Sets
Australian dialect reference set